Muscle wasting in cancer: opportunities and challenges for exercise in clinical cancer trials
Abstract Background Low muscle in cancer is associated with an increase in treatment‐related toxicities and is a predictor of cancer‐related and all‐cause mortality. The mechanisms of cancer‐related muscle loss are multifactorial, including anorexia, hypogonadism, anaemia, inflammation, malnutrition...
Saved in:
Main Authors: | Ciaran M. Fairman (Author), Simon Lønbro (Author), Thomas D. Cardaci (Author), Brandon N. VanderVeen (Author), Tormod S. Nilsen (Author), Angela E. Murphy (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia
by: Thomas D. Cardaci, et al.
Published: (2024) -
Designing effective exercise intervention trials for prostate cancer cohorts: a qualitative study on experiences and views of exercise oncology researchers
by: Kira Murphy, et al.
Published: (2023) -
Construction and Demolition Waste: Challenges and Opportunities
Published: (2022) -
Inflammatory signalling regulates eccentric contraction‐induced protein synthesis in cachectic skeletal muscle
by: Justin P. Hardee, et al.
Published: (2018) -
Mechanisms of chemotherapy‐induced muscle wasting in mice with cancer cachexia
by: Kate T. Murphy, et al.
Published: (2022)